Dcf Advisers, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Dcf Advisers, LLC

$242 Million
Q3 2024

A detailed history of Dcf Advisers, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dcf Advisers, LLC holds 7,750 shares of REGN stock, worth $5.5 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares

7,750

Previous 10,400 25.48%

Holding current value

$5.5 Million

Previous $10.9 Million 25.46%

% of portfolio

3.37%

Previous 5.91%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $2.71 Million - $3.18 Million	-2,650 Reduced 25.48%	7,750 $8.15 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $176,640 - $214,238	-200 Reduced 1.89%	10,400 $10.9 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $1.44 Million - $1.59 Million	-1,600 Reduced 13.11%	10,600 $10.2 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $1.03 Million - $1.17 Million	1,325 Added 12.18%	12,200 $10.7 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $207,735 - $253,311	-300 Reduced 2.68%	10,875 $8.95 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $105,004 - $124,552	150 Added 1.36%	11,175 $8.03 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $85,061 - $103,371	125 Added 1.15%	11,025 $9.06 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $105,883 - $114,958	-150 Reduced 1.36%	10,900 $7.86 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $947,050 - $1.2 Million	-1,650 Reduced 12.99%	11,050 $7.61 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $1.1 Million - $1.48 Million	-2,000 Reduced 13.61%	12,700 $7.51 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.49 Million - $1.75 Million	-2,500 Reduced 14.53%	14,700 $10.3 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $652,176 - $805,164	1,200 Added 7.5%	17,200 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $287,015 - $340,480	500 Added 3.23%	16,000 $9.68 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $945,600 - $1.12 Million	2,000 Added 14.81%	15,500 $8.66 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $491,403 - $603,020	1,100 Added 8.87%	13,500 $6.39 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $123,330 - $160,980	250 Added 2.06%	12,400 $7.73 Million
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $420,225 - $618,037	-1,250 Reduced 9.33%	12,150 $5.93 Million
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $3.67 Million - $5.05 Million	13,400 New	13,400 $5.03 Million

Others Institutions Holding REGN

# of Institutions

1,484

Shares Held

83.7M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account